Iovance Biotherapeutics
IOVA
#5408
Rank
S$1.32 B
Marketcap
$4.04
Share price
-7.69%
Change (1 day)
-77.99%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2024 (TTM): -S$0.53 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are S$0.16 Billion. , an increase over its 2023 earnings that were of -S$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.54 Billion-14.17%
2023 -S$0.62 Billion15.46%
2022 -S$0.54 Billion16.39%
2021 -S$0.47 Billion30.83%
2020 -S$0.36 Billion26.62%
2019 -S$0.28 Billion61.29%
2018 -S$0.18 Billion38.09%
2017 -S$0.13 Billion73.16%
2016 -S$72.17 Million92.7%
2015 -S$37.46 Million131.17%
2014 -S$16.21 Million-51.71%
2013 -S$33.56 Million6291.81%
2012 -S$0.53 Million
2008 -S$0.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$47.47 M-108.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$2.91 Million-99.45% Bahamas